Based on the basic pathological features of COVID-19, which include dysregulation of the lung mucosa and the massive production of mucus, it is reasonable to speculate that IL-13 is likely to be closely related to the pathological progression to severe COVID-19. This evidence concerns the gene IL13 and COVID-19.